Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 394,585 | 483,610 | 206,395 | 254,312 | 135,376 |
| Marketable Securities | 37,713 | 43,332 | 39,103 | 55,371 | 91,065 |
| Receivables | 238,347 | 103,035 | 78,447 | 84,564 | 88,156 |
| TOTAL | $696,915 | $665,777 | $339,872 | $413,273 | $325,501 |
| Non-Current Assets | |||||
| PPE Net | 369,959 | 367,955 | 363,913 | 361,883 | 357,423 |
| Investments And Advances | 254,738 | 275,887 | 258,073 | 251,256 | 373,621 |
| Other Non-Current Assets | 28,547 | 13,964 | 21,173 | 20,452 | 17,748 |
| TOTAL | $653,244 | $657,806 | $643,159 | $633,591 | $748,792 |
| Total Assets | $1,350,159 | $1,323,583 | $983,031 | $1,046,864 | $1,074,293 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 106,723 | 95,625 | 78,890 | 81,665 | 58,602 |
| TOTAL | $160,386 | $148,271 | $133,235 | $135,868 | $112,252 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 52,570 | 51,640 | 53,425 | 53,326 | 52,852 |
| aiOther Non-Current Liabilities | 287,661 | 281,462 | 7,405 | 6,806 | 7,180 |
| TOTAL | $685,749 | $689,580 | $421,543 | $432,962 | $443,950 |
| Total Liabilities | $846,135 | $837,851 | $554,778 | $568,830 | $556,202 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 95,122 | 93,889 | 92,576 | 91,627 | 90,891 |
| Common Shares | 95 | 93 | 92 | 91 | 91 |
| Retained earnings | -1,255,672 | -1,267,323 | -1,213,880 | -1,151,515 | -1,089,010 |
| Other shareholders' equity | -1,337 | -1,862 | -1,731 | -904 | -2,175 |
| TOTAL | $504,024 | $485,732 | $428,253 | $478,034 | $518,091 |
| Total Liabilities And Equity | $1,350,159 | $1,323,583 | $983,031 | $1,046,864 | $1,074,293 |